News
Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...
TAMPA — Florida’s top health official blasted the manufacturer’s of mRNA COVID-19 vaccines and wants the federal government to do more to help those he described as the “vaccine injured.” Florida ...
Moderna Japan had planned to build an mRNA drug plant at Shonan Health Innovation Park in Kanagawa prefecture. The company shelved the plan, citing weak demand for vaccines and a poor business ...
Researchers are ushering in a new era of vaccine design that promises to be faster, more precise, and capable of tackling humanity’s most stubborn diseases.
Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...
When ticks bite us, they release thousands of proteins through their saliva. Could a vaccine for the right ones stop ticks ...
The UK government has revealed a plan to open a biosecurity facility in Harlow, Essex, to help protect the country from ...
If you have had a similar reaction to Pfizer's COVID-19 vaccine, email chris.melore@dailymail.com with your storyScientists ...
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
Many of the 17 million projected to lose Medicaid coverage will turn to struggling free health clinics. They need more ...
TheStreet. Big Blue is making a quantum leap — for real. International Business Machines (IBM) , which once held most of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results